Lucid Diagnostics Inc (LUCD)

Dec 10, 2025

Lucid Diagnostics Stock (LUCD) Opinions on Recent Clinical Data Release - Quiver Quantitative

Dec 10, 2025

Dec 10, 2025

Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq

Dec 10, 2025

Dec 10, 2025

Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital By Investing.com - Investing.com South Africa

Dec 10, 2025

Dec 10, 2025

Lucid Diagnostics stock price target raised to $8.25 at Ascendiant Capital - Investing.com Canada

Dec 10, 2025

Dec 09, 2025

Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Nigeria

Dec 09, 2025

Dec 09, 2025

Lucid Diagnostics (LUCD) Stock: Surge After Real-World EsoGuard Data Breakthrough! - parameter.io

Dec 09, 2025

Dec 09, 2025

Lucid Diagnostics (Nasdaq: LUCD) reports 95% EsoCheck success in 11,991 patients - Stock Titan

Dec 09, 2025

Dec 08, 2025

Lucid Diagnostics files for $175 mln mixed securities shelf offering - MSN

Dec 08, 2025

Dec 05, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus

Dec 05, 2025

Dec 04, 2025

A Look at Lucid Diagnostics Inc (LUCD) Shares in the Recent Past Indicates Growth - Setenews

Dec 04, 2025

Dec 04, 2025

Should I hold or sell Lucid Diagnostics Inc. stock in 2025Weekly Market Outlook & Weekly High Return Stock Opportunities - Newser

Dec 04, 2025

Dec 03, 2025

Why Lucid Diagnostics Inc. stock appeals to analysts2025 Retail Activity & Safe Investment Capital Preservation Plans - Newser

Dec 03, 2025

Dec 02, 2025

Lucid Diagnostics (LUCD) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Dec 01, 2025

Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN

Dec 01, 2025

Nov 29, 2025

Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance

Nov 29, 2025

Nov 28, 2025

Is Lucid Diagnostics Inc (LUCD) positioned for future growth? - Setenews

Nov 28, 2025

Nov 25, 2025

Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry

Nov 25, 2025

Nov 20, 2025

Get in on Lucid Diagnostics Inc’s (LUCD) buy-in window today! - Setenews

Nov 20, 2025

Nov 20, 2025

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire

Nov 20, 2025

Nov 20, 2025

Ranking Lucid Diagnostics Inc. among high performing stocks via tools2025 Top Decliners & AI Powered Trade Plan Recommendations - newser.com

Nov 20, 2025

Nov 20, 2025

Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Canada

Nov 20, 2025

Nov 19, 2025

Developing predictive dashboards with Lucid Diagnostics Inc. dataBear Alert & Fast Gain Swing Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Lucid Diagnostics stock maintains Overweight rating at Cantor Fitzgerald - Investing.com

Nov 19, 2025

Nov 19, 2025

Live market analysis of Lucid Diagnostics Inc.Weekly Market Report & Long Hold Capital Preservation Tips - newser.com

Nov 19, 2025

Nov 18, 2025

Why retail investors favor Lucid Diagnostics Inc. stockAnalyst Downgrade & Stock Portfolio Risk Control - newser.com

Nov 18, 2025

Nov 18, 2025

Is Lucid Diagnostics Inc. stock oversold or undervaluedMarket Growth Report & Pattern Based Trade Signal System - newser.com

Nov 18, 2025

Nov 18, 2025

Measuring Lucid Diagnostics Inc.’s beta against major indices - newser.com

Nov 18, 2025

Nov 18, 2025

Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - TipRanks

Nov 18, 2025

Nov 17, 2025

Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges - MSN

Nov 17, 2025

Nov 16, 2025

Combining machine learning predictions for Lucid Diagnostics Inc.2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Why Lucid Diagnostics Inc. stock is considered a top pickJuly 2025 Momentum & Community Consensus Picks - newser.com

Nov 16, 2025

Nov 16, 2025

Is Lucid Diagnostics Inc. meeting your algorithmic filter criteriaEarnings Performance Report & Weekly Momentum Stock Picks - newser.com

Nov 16, 2025

Nov 16, 2025

Lucid Diagnostics (NASDAQ:LUCD) Cut to Sell at Wall Street Zen - MarketBeat

Nov 16, 2025

Nov 15, 2025

Earnings call transcript: Lucid Diagnostics Q3 2025 reports revenue growth and strategic advancements - Investing.com Nigeria

Nov 15, 2025

Nov 14, 2025

Lucid Diagnostics Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:LUCD) 2025-11-14 - Seeking Alpha

Nov 14, 2025

Nov 14, 2025

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Eastern Progress

Nov 14, 2025

Nov 14, 2025

How supply chain issues affect Lucid Diagnostics Inc. stockJuly 2025 Setups & Daily Profit Focused Screening - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources

Nov 14, 2025

Nov 13, 2025

Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 13, 2025

Nov 13, 2025

Lucid Diagnostics Gains Medicare Support for EsoGuard - MSN

Nov 13, 2025

Nov 13, 2025

Is Lucid Diagnostics Inc. stock ready for a breakoutJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com

Nov 13, 2025

Nov 13, 2025

Needham reiterates Buy rating on Lucid Diagnostics stock amid EsoGuard growth By Investing.com - Investing.com South Africa

Nov 13, 2025